Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Enveric Biosciences, Inc. (ENVB)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
3.1000+0.1900 (+6.53%)
At close: 03:59PM EST
3.1400 +0.04 (+1.29%)
After hours: 07:48PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/4/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 367.5000
52 Week Low 32.6100
50-Day Moving Average 33.5437
200-Day Moving Average 38.8931

Share Statistics

Avg Vol (3 month) 370.29k
Avg Vol (10 day) 344.93k
Shares Outstanding 531.38M
Implied Shares Outstanding 6N/A
Float 81.45M
% Held by Insiders 19.66%
% Held by Institutions 19.04%
Shares Short (Oct 13, 2022) 451.17k
Short Ratio (Oct 13, 2022) 40.83
Short % of Float (Oct 13, 2022) 42.50%
Short % of Shares Outstanding (Oct 13, 2022) 42.46%
Shares Short (prior month Sep 14, 2022) 482.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 24, 2019
Ex-Dividend Date 4Apr 22, 2008
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.00%
Return on Equity (ttm)-251.71%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.17M
Net Income Avi to Common (ttm)-52.21M
Diluted EPS (ttm)-0.6740
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.01M
Total Cash Per Share (mrq)11.44
Total Debt (mrq)120.97k
Total Debt/Equity (mrq)0.54
Current Ratio (mrq)8.33
Book Value Per Share (mrq)1.76

Cash Flow Statement

Operating Cash Flow (ttm)-15.41M
Levered Free Cash Flow (ttm)-4.49M
Advertisement
Advertisement